ImmunoPrecise Antibodies Ltd (IPA)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
May 17, 16:00
1.19
+0.01
(+0.85%)
Pre-Market: 20:00
ImmunoPrecise Antibodies 1 Year Total Returns (Daily): -60.00% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -60.00% |
May 16, 2024 | -60.14% |
May 15, 2024 | -62.47% |
May 14, 2024 | -70.30% |
May 13, 2024 | -68.81% |
May 10, 2024 | -54.42% |
May 09, 2024 | -53.16% |
May 08, 2024 | -53.28% |
May 07, 2024 | -52.56% |
May 06, 2024 | -51.44% |
May 03, 2024 | -53.28% |
May 02, 2024 | -50.78% |
May 01, 2024 | -51.36% |
April 30, 2024 | -50.19% |
April 29, 2024 | -46.69% |
April 26, 2024 | -54.95% |
April 25, 2024 | -58.83% |
April 24, 2024 | -59.87% |
April 23, 2024 | -60.39% |
April 22, 2024 | -59.42% |
April 19, 2024 | -53.16% |
April 18, 2024 | -53.21% |
April 17, 2024 | -50.78% |
April 16, 2024 | -49.01% |
April 15, 2024 | -50.99% |
Date | Value |
---|---|
April 12, 2024 | -50.72% |
April 11, 2024 | -51.93% |
April 10, 2024 | -52.23% |
April 09, 2024 | -51.75% |
April 08, 2024 | -50.35% |
April 05, 2024 | -40.50% |
April 04, 2024 | -42.46% |
April 03, 2024 | -42.00% |
April 02, 2024 | -46.93% |
April 01, 2024 | -44.77% |
March 28, 2024 | -45.32% |
March 27, 2024 | -45.49% |
March 26, 2024 | -48.65% |
March 25, 2024 | -48.65% |
March 22, 2024 | -46.78% |
March 21, 2024 | -54.55% |
March 20, 2024 | -54.22% |
March 19, 2024 | -56.19% |
March 18, 2024 | -57.70% |
March 15, 2024 | -61.60% |
March 14, 2024 | -59.13% |
March 13, 2024 | -57.33% |
March 12, 2024 | -58.38% |
March 11, 2024 | -55.58% |
March 08, 2024 | -53.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.56%
Minimum
Dec 12 2023
750.0%
Maximum
Dec 29 2020
33.99%
Average
-25.03%
Median
Oct 19 2021
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | -10.35% |
Aurinia Pharmaceuticals Inc | -46.22% |
Edesa Biotech Inc | -30.85% |
Lexaria Bioscience Corp | 326.5% |
Xenon Pharmaceuticals Inc | -3.66% |